113 related articles for article (PubMed ID: 7511332)
21. Establishment of a human megakaryoblastic cell line (T-33) from chronic myelogenous leukemia in megakaryoblastic crisis.
Tange T; Nakahara K; Mitani K; Yamasaki I; Yasuda H; Tanaka F; Mizuguchi M; Oda H; Yatomi Y; Takanashi R
Cancer Res; 1988 Nov; 48(21):6137-44. PubMed ID: 3167860
[TBL] [Abstract][Full Text] [Related]
22. Cytoplasmic GpIIb-IIIa and cytokine secretion by blasts in a case of megakaryoblastic transformation of essential thrombocythemia.
Selleri C; Alfinito F; Del Vecchio L; Luciano L; De Renzo A; Rotoli B
Leuk Lymphoma; 1993 Aug; 10(6):497-500. PubMed ID: 8401187
[TBL] [Abstract][Full Text] [Related]
23. Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival.
Komatsu N; Nakauchi H; Miwa A; Ishihara T; Eguchi M; Moroi M; Okada M; Sato Y; Wada H; Yawata Y
Cancer Res; 1991 Jan; 51(1):341-8. PubMed ID: 1824823
[TBL] [Abstract][Full Text] [Related]
24. Dynamic redistribution of major platelet surface receptors after contact-induced platelet activation and spreading. An immunoelectron microscopy study.
Kieffer N; Guichard J; Breton-Gorius J
Am J Pathol; 1992 Jan; 140(1):57-73. PubMed ID: 1309961
[TBL] [Abstract][Full Text] [Related]
25. Effects of c-mpl ligand on cytoplasmic maturation of murine megakaryocytes and on platelet production.
Ishida Y; Ito T; Kuriya Si
J Histochem Cytochem; 1998 Jan; 46(1):49-57. PubMed ID: 9405494
[TBL] [Abstract][Full Text] [Related]
26. Differentiation induction of blast cells in two cases of childhood acute megakaryoblastic leukemia in vitro by interleukin-3 and interleukin-6: an ultrastructural cytochemical study.
Miyauchi J; Sugita K; Okui M; Taguchi N; Clark SC; Shimizu K
J Cell Physiol; 1991 Sep; 148(3):404-13. PubMed ID: 1655816
[TBL] [Abstract][Full Text] [Related]
27. Apoptosis of erythroid precursors under stimulation with thrombopoietin: contribution to megakaryocytic lineage choice.
Sawai N; Koike K; Ito S; Kurokawa Y; Mwamtemi HH; Kinoshita T; Sakashita K; Higuchi T; Takeuchi K; Shiohara M; Ogami K; Komiyama A
Stem Cells; 1999; 17(1):45-53. PubMed ID: 10215401
[TBL] [Abstract][Full Text] [Related]
28. Cell surface antigen expression in human erythroid progenitors: erythroid and megakaryocytic markers.
Nakahata T; Okumura N
Leuk Lymphoma; 1994 May; 13(5-6):401-9. PubMed ID: 8069185
[TBL] [Abstract][Full Text] [Related]
29. Down's syndrome and acute leukemia in children: an analysis of phenotype by use of monoclonal antibodies and electron microscopic platelet peroxidase reaction.
Kojima S; Matsuyama T; Sato T; Horibe K; Konishi S; Tsuchida M; Hayashi Y; Kigasawa H; Akiyama Y; Okamura J
Blood; 1990 Dec; 76(11):2348-53. PubMed ID: 2147864
[TBL] [Abstract][Full Text] [Related]
30. Expression of CD56/NCAM on hematopoietic malignant cells. A useful marker for acute monocytic and megakaryocytic leukemias.
Ikushima S; Yoshihara T; Matsumura T; Misawa S; Morioka Y; Hibi S; Imashuku S
Int J Hematol; 1991 Oct; 54(5):395-403. PubMed ID: 1721853
[TBL] [Abstract][Full Text] [Related]
31. [Apoptosis of Megakaryocytic Leukemia Cell Line Meg-01 Induced by TSP-1 Via CD36/Caspase-3].
Kong HM; Su WQ; Luo Y; Ge H; Li L; Yang M; Jiang QL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):998-1004. PubMed ID: 35981353
[TBL] [Abstract][Full Text] [Related]
32. Platelet factor 4 gene expression in a human megakaryocytic leukemia cell line (CMK) and its differentiated subclone (CMK11-5).
Adachi M; Ryo R; Sato T; Yamaguchi N
Exp Hematol; 1991 Oct; 19(9):923-7. PubMed ID: 1893970
[TBL] [Abstract][Full Text] [Related]
33. Acute megakaryoblastic leukemia in children identified by immunological marker studies.
Hirt A; Luethy AR; Mueller B; Gugler E; Wagner HP
Am J Pediatr Hematol Oncol; 1990; 12(1):27-33. PubMed ID: 2178458
[TBL] [Abstract][Full Text] [Related]
34. CD36 (thrombospondin receptor) expression in childhood acute megakaryoblastic leukemia: in vitro drug sensitivity and outcome.
Savaşan S; Buck S; Raimondi SC; Becton DL; Weinstein H; Chang M; Ravindranath Y
Leuk Lymphoma; 2006 Oct; 47(10):2076-83. PubMed ID: 17071479
[TBL] [Abstract][Full Text] [Related]
35. [Surface antigens of megakaryocytes].
Koike T; Furukawa T
Rinsho Byori; 1991 Sep; Suppl 91():205-16. PubMed ID: 1758071
[No Abstract] [Full Text] [Related]
36. Cell surface phenotyping of megakaryoblasts.
Koike T; Aoki S; Maruyama S; Narita M; Ishizuka T; Imanaka H; Adachi T; Maeda H; Shibata A
Blood; 1987 Mar; 69(3):957-60. PubMed ID: 3028539
[TBL] [Abstract][Full Text] [Related]
37. Leukemic blasts with markers of four cell lineages in Down's syndrome ("megakaryoblastic leukemia").
Slørdahl SH; Smeland EB; Holte H; Grønn M; Lie SO; Seip M
Med Pediatr Oncol; 1993; 21(4):254-8. PubMed ID: 8469219
[TBL] [Abstract][Full Text] [Related]
38. Replication and endoreplication in developing megakaryocytes in vitro.
Angchaisuksiri P; Carlson PL; Day EB; Dessypris EN
Exp Hematol; 1994 Jul; 22(7):546-50. PubMed ID: 7516888
[TBL] [Abstract][Full Text] [Related]
39. Characterization of a new megakaryocytic cell line: the Dami cell.
Greenberg SM; Rosenthal DS; Greeley TA; Tantravahi R; Handin RI
Blood; 1988 Dec; 72(6):1968-77. PubMed ID: 3196874
[TBL] [Abstract][Full Text] [Related]
40. Extramedullary tumor as presentation of leukemia: establishment of a new human GPIIb- and GPIIIa-positive leukemia cell line.
Yasunaga M; Ryo R; Konaka Y; Sawada S; Taniguchi H; Sawada H; Goto M; Jikai J; Sugano W; Saigo K
Ann Hematol; 1994 Mar; 68(3):145-51. PubMed ID: 8167181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
